Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

NCT05551767 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Neck Cancer

Interventions

DRUG: Pembrolizumab

Sponsor

City Clinical Oncology Hospital No 1

Collaborators

[object Object]
[object Object]